BTRC Knockout HeLa Cell Line
Cat.No.:
EDC90409
Species:
Human
Cell Name:
HeLa
Gene:
BTRC
Gene ID:
8945
Size:
1×10⁶cells
BTRC Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90409 |
|---|---|
| Product Name | BTRC Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | BTRC |
| NCBI Gene ID | |
| Gene Synonyms | BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP |
| Summary |
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbws class; in addition to an F-box, this protein contains multiple WD-40 repeats. The encoded protein mediates degradation of CD4 via its interaction with HIV-1 Vpu. It has also been shown to ubiquitinate phosphorylated NFKBIA (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha), targeting it for degradation and thus activating nuclear factor kappa-B. Alternatively spliced transcript variants have been described. A related pseudogene exists in chromosome 6. [provided by RefSeq, Mar 2012]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70%Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying BTRC function, BTRC Knockout HeLa Cell Line or BTRC overexpression HeLa Cell Line?
The choice depends on whether you are studying BTRC (β-TrCP1, FBXW1)'s role as a major SCF E3 ligase substrate receptor or modeling its broad biological functions. The Knockout line is the standard tool for asking whether β-TrCP is required for these processes — BTRC is one of two β-TrCP paralogs (BTRC/FBXW1 and FBXW11/β-TrCP2) that serve as F-box substrate receptors in SCF^β-TrCP E3 ubiquitin ligase complexes; β-TrCP recognizes phosphodegron motifs (DSGxxS) on diverse substrates including IκBα (NF-κB signaling), β-catenin (Wnt signaling, recognized by both β-TrCP and APC pathways), Cdc25A (DNA damage response), Emi1, REST, and many others. Overexpression is useful for studying BTRC in heterologous expression contexts.
Important consideration: BTRC and FBXW11/β-TrCP2 share substantial substrate scope — single BTRC knockout may show modest phenotypes if FBXW11 compensates. For ubiquitin biology research, the EDITGENE BTRC Knockout in HeLa enables study of β-TrCP1-specific functions. Rescue with wild-type or substrate-binding-deficient BTRC is the standard specificity control. The knockout is valuable for studying NF-κB activation (IκBα degradation), Wnt signaling (β-catenin degradation), DNA damage response (Cdc25A degradation), and emerging targeted protein degradation approaches using β-TrCP-recruiting PROTACs.
What are the application scenarios for this model?
Primary applications:
• Substrate stability: IκBα, β-catenin, Cdc25A, Emi1, REST protein stability analysis (cycloheximide chase) in BTRC-null cells.
• NF-κB signaling: TNF-α-induced IκBα degradation kinetics and downstream NF-κB activation.
• Wnt signaling: β-catenin destruction complex analysis given β-TrCP's role.
• FBXW11/β-TrCP2 paralog studies: FBXW11 expression analysis to interpret BTRC-specific functions.
• β-TrCP-recruiting PROTAC platform development: emerging E3 ligase substrate receptor expansion beyond CRBN/VHL.
EDITGENE recommends this model for researchers investigating β-TrCP-mediated ubiquitination, NF-κB regulation, and emerging β-TrCP-recruiting PROTACs.
Is this BTRC Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. BTRC rescue experiments require attention to F-box substrate receptor architecture:
• Construct design: use a codon-modified BTRC sequence with a small C-terminal tag (FLAG, HA). BTRC has N-terminal F-box domain (SKP1 binding) and C-terminal WD40 domain (substrate phosphodegron binding) — preserve all elements.
• Substrate-binding-deficient rescue: WD40 domain mutations disrupt phosphodegron substrate binding.
• F-box-deficient rescue: F-box mutations disrupt SCF complex assembly.
• Functional readout: rescue should restore IκBα/β-catenin/Cdc25A degradation.
HeLa transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download